Bristol Myers Squibb to Present Oncology Data at ESMO 2026
Bristol Myers Squibb said it will present new data from its oncology portfolio and pipeline across solid tumors at the ESMO 2026 Congress, scheduled for October 23–27 in Madrid.
Bristol Myers Squibb said it will present new data from its oncology portfolio and pipeline across solid tumors at the ESMO 2026 Congress, scheduled for October 23–27 in Madrid.